Clinical Trials Logo
  1. Home
  2. Actinic Cheilitis
  3. NCT00849992

Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy

Actinic Cheilitis Clinical Trial

Official title:
Randomized Prospective Study Comparing 5% Imiquimod and Photodynamic Therapy for Actinic Cheilitis

Clinical Trial Summary

Actinic cheilitis is a common precancerous lesion of the lip. The purpose of this study is to compare imiquimod 5% therapy and photodynamic therapy. The data will include effect data, histology (skin analysis), epidemiological data and follow-up data.

Clinical Trial Description

Randomized study comparing imiquimod 5% with photodynamic therapy for actinic cheilitis. Histological, efficacy, epidemiological and clinical data will be collected. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00849992
Study type Interventional
Source Norwegian University of Science and Technology
Contact
Status Completed
Phase Phase 4
Start date March 2009
Completion date November 2013
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT03224715 - Actinic Cheilitis Pre-Treated With DNA Repair Enzyme Cream N/A
Not yet recruiting NCT03990636 - Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial Phase 2
Terminated NCT04219358 - Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis Phase 1
Recruiting NCT06321003 - SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Recruiting NCT04744103 - Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis Phase 4
Completed NCT00868088 - Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip Phase 4
Completed NCT02198469 - Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis Phase 1
Withdrawn NCT03452566 - Evaluation of Ingenol Mebutate for Actinic Cheilitis Treatment Phase 1/Phase 2
Completed NCT02409732 - Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis Phase 4